Prevention of secondary osteoporosis postmenopause in hemiplegia

American Journal of Physical Medicine and Rehabilitation

Volumn 80, Issue 3, 2001, Pages 169-174

  Ikai, Tetsuo ^a,b   Uematsu, Mikumo ^a   Eun, Sang Soo ^a   Kimura, Chiko ^a   Hasegawa, Chieko ^a   Miyano, Satoshi ^a  

^a JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Tokyo Metropolitan Rehabilitation Hospital   (Japan)

Author keywords

Activities of daily living; Etidronate; Hemiplegic women; Secondary osteoporosis

Indexed keywords

BIOCHEMICAL MARKER; ETIDRONIC ACID;

ADULT; AGED; ARTICLE; BONE DENSITY; BONE MINERAL; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE ASSOCIATION; DISEASE COURSE; DRUG EFFICACY; FEMALE; HEMIPLEGIA; HUMAN; OSTEOPOROSIS; PARESIS; POSTMENOPAUSE; STOMACH PAIN;

ABSORPTIOMETRY, PHOTON; ACTIVITIES OF DAILY LIVING; AGED; ALKALINE PHOSPHATASE; AMINO ACIDS; BONE DENSITY; DISEASE PROGRESSION; ETIDRONIC ACID; FEMALE; FOLLOW-UP STUDIES; GERIATRIC ASSESSMENT; HEMIPLEGIA; HUMANS; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 0035125657     PISSN: 08949115     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002060-200103000-00003     Document Type: Article

References (31)

1. The fractured hip in hemiplegic patients
2. Hip fracture after hemiplegia
3. Fractures after stroke
4. Assessment of osteoporosis in hemiplegic patients using MD/MS method
5. Clinical study of bone atrophy on hemiplegic patients after cerebrovascular accidents
6. A study on osteoporosis in the stroke patients using bone mineral density and biochemical marker
7. Progressive osteoporosis of the femoral neck in patients with hemiplegia: Effect of ambulatory ability
8. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis
9. Bisphosphonates: Preclinical aspects and use in osteoporosis
10. Radioimmunoassay of the vitamin K-dependent protein of bone and its discovery in plasma
11. Quantitative analysis of the pyridinium crosslinks of collagen in urine using ion-paired reverse-phase high-performance liquid chromatography
12. Radioimmunoassay for pyridinoline cross-linked carboxy-terminal telopeptide of type I collagen: A new serum marker of bone collagen degradation
13. Prophylaxis and treatment of osteoporosis
14. Osteoporosis in hemiplegia
15. Progressive osteoporosis in hemiplegia
16. Bone mineralization in the distal forearm of hemiplegic patients
17. Forearm bone loss in hemiplegia: A model for the study of immobilization osteoporosis
18. The effect of hemiplegia on bone mass and soft tissue body composition
19. Alterations of bone mineral density of the femurs in hemiplegia
20. Long-term effects of strokes on bone mass
21. Determinants of bone mineral density in immobilization: A study on hemiplegic patients
22. Prevention of falls in the hemiplegic patients
23. Influence of weightbearing and muscle contraction on disuse osteoporosis
24. Increased bone resorption during the first year after stroke
25. The long-term effect of menopause on postmenopausal bone loss in Japanese women: Results from a prospective study
26. Upper gastrointestinal adverse events and cyclical etidronate
27. Utility of biochemical markers of bone turnover in the follow-up of patients treated with bisphosphonates
28. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy respectively in tail-suspended rats
29. Amelioration of hemiplegia-associated oeteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamine D3 and calcium supplementation
30. Effect of ipriflavone on bone in elderly hemiplegic stroke patients with hypovitaminosis D